Navigation Links
Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
Date:9/3/2008

of the open-label, large sample, multi-center Endu phase IV clinical study affirms the safety and therapeutic efficacy of Endu acting in conjunction with platinum-based chemotherapy. With our continued research of Endu Phase IV, we will collect more clinical data to further evaluate the safety and efficacy of Endu."

To date, over 2,000 NSCLC patients have been recruited for Endu Phase IV clinical study. The final results of the study will be announced in the first half of 2010.

As a leading patented anti-cancer biotech product in China, Endu is recommended in the National Comprehensive Cancer Network of China Clinical Practice Guidelines in Oncology Chinese Version (2006-2008)as a first line treatment for NSCLC.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has been focusing its strategy on the development of first-to-market generic and innovative pharmaceuticals, and has introduced a first-to-market generic stroke management medication under the brand name Bicun and an innovative anti-cancer medication under the brand name Endu. Simcere currently manufactures and sells more than 50 pharmaceutical products including antibiotics, anti-cancer medication and stroke management medication and is the exclusive distributor of three additional pharmaceuticals that are marketed under its brand names. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmac
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
2. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
3. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
4. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
5. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
6. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
7. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
8. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
9. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
11. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Michigan brothers Dominique Larkin , 23, and ... ventricular dysplasia, or ARVD, a disease that causes irregular heart ... young athletes. In 2007, doctors discovered the condition ... later tested Dominique and found his "condition was just as ... story in The Ann Arbor News , part of ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of the "Global Ultrasound ... , The Global Ultrasound ... 5.79% over the period 2014-2019 Ultrasound ... sound waves. Ultrasound systems are extensively used by ...
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
Breaking Medicine Technology:Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2VWR Announces Expansion of Distribution Agreement with New England Biolabs 2
... LAWRENCE, Mass., Jan. 4, 2011 NxStage Medical, Inc. ... innovative dialysis products, today announced that Jeffrey H. Burbank, ... Officer, will present at the 29th Annual J.P. Morgan ... a.m. (PST). The live webcast of NxStage,s ...
... Pharmaceuticals, Inc. (Nasdaq: OPTR ) today announced ... granted orphan drug designation from the U.S. Food and ... Clostridium difficile infection (CDI).  This orphan drug designation ... of fidaxomicin used to treat Clostridium difficile ...
Cached Medicine Technology:NxStage to Present at the 29th Annual J.P. Morgan Healthcare Conference 2Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 2Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 3Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 4
(Date:3/3/2015)... (PRWEB) March 03, 2015 Today, Steve ... former Seattle Seahawks wide receiver, announced the donation of ... timing with Brain Injury Awareness Month. In an effort ... and the importance of brain health, Rice and Weatherford ... and the need to make brain health a priority ...
(Date:3/3/2015)... Angeles, Ca (PRWEB) March 03, 2015 Dan ... with a special focus on capital crimes, recently spoke ... “American Sniper” murder trial. The hosts of the Independent Journal ... knew his history working first as a prosecutor and now ... insight into the decisions made in the trial and sentencing ...
(Date:3/3/2015)... The human augmentation market is mainly driven by ... augmentation sector is predicted to outpace the in-built augmentation ... , The eye-wear sector dominates the North American ... new products launches in the region. Furthermore, strong economy ... well as the rising demand for advantageous products in ...
(Date:3/3/2015)... While it is clear that the prospect ... Canadian drivers are signing up to UBI policies, more ... be enticed. Due to current regulations, the application of ... Its full capability is starting to be realised ... emergency breakdown services are at the top of the ...
(Date:3/3/2015)... 03, 2015 DePuy Pinnacle hip ... version of the artificial hip system caused recipients ... move forward in the federal multidistrict litigation underway ... According to the most recent Master Case List ... 7,350 Pinnacle hip replacement lawsuits are now pending ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4
... has directed the state prisons department to provide ayurvedic treatment ... 1998// serial blasts Abdul Nasser Mahdhani in the central prison ... arrest in March 1998, 45 days after the serial blasts, ... blood pressure, diabetes, spinal proble and weight loss. He also ...
... of India wants the Government and people to work together ... donation. In India., ,Inaugurating the blood bank of ... asked the government and people to work in tandem for ... organs must be encouraged to save precious lives, especially that ...
... gene that facilitates the spread of malignant melanoma, a ... speed the discovery of hard-to-find cancer genes. ,A ... Lynda Chin, MD, report that the gene, NEDD9, is ... that have metastasized, but not in primary melanomas that ...
... subject as sex is, perhaps vying with each other for ... known - responsible //for many diseases, failed pregnancy, miscarriage, etc. ... host of problems, like ADHD in the child and premature ... memory and hormonal cycles. ,Women seem to be twice ...
... that the antipsychotic drug, clozapine has some very concerning ... available. ,"Clozapine is the last hope for ... study suggests that patients who need the most effective ... said J. Steven Lamberti, the lead author of the ...
... Paris have concluded that at least one decade is needed ... Dr. David Fedson, former professor// of medicine at the University ... was nothing short of a catastrophe for the public. ... work with for three years and after three years this ...
Cached Medicine News:Health News:Researchers have Identified the Gene that Spreads Skin Cancer 2
... for applications in the field of point of ... used as a back-up instrument in routine pathology ... safety clamps for the cover, the CM1100 can ... optional 12-volt transformer, it can be run on ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
... advanced smart processor for paraffin infiltration of ... Proven and enhanced technology with an innovative ... the hallmark of the Leica ASP200. Many ... includes a variety of SMART features to ...
... A totally new concept in a power ... and sliding microtomes. Power assisted horizontal movements ... moving across the knife edge. Duplicate controls ... or right hand while the operating levers ...
Medicine Products: